beherenow personal page - To The Moon

beherenow

No personal profile

3Follow

1Followers

0Topic

0Badge

2023-12-10

Thanks for detailed and thorough article. Very helpful and plenty of useful information. Even if one doesn't follow the outlined strategy to a T, there's good info in stocks to buy, and other instruments.

Sorry, the original content has been removed

2023-12-09

If I could rewind time, I'd go to just before covid hit and invest into a large range of biotech firms, and also large online retailers, and then a bunch into AI related stocks.

2023-12-05

Keeping an eye on this.

Sorry, the original content has been removed

2023-12-01

Good tips.

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":4133911624467882,"uuid":"4133911624467882","gmtCreate":1700254924119,"gmtModify":1700732837651,"name":"beherenow","pinyin":"beherenow","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":3,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":18,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":250584258953496,"gmtCreate":1702196866968,"gmtModify":1702197639190,"author":{"id":"4133911624467882","authorId":"4133911624467882","name":"beherenow","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Thanks for&nbsp; detailed and thorough article. Very helpful and plenty of useful information. Even if one doesn't follow the outlined strategy to a T, there's good info in stocks to buy, and other instruments.&nbsp;","listText":"Thanks for&nbsp; detailed and thorough article. Very helpful and plenty of useful information. Even if one doesn't follow the outlined strategy to a T, there's good info in stocks to buy, and other instruments.&nbsp;","text":"Thanks for detailed and thorough article. Very helpful and plenty of useful information. Even if one doesn't follow the outlined strategy to a T, there's good info in stocks to buy, and other instruments.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/250584258953496","repostId":"2390181028","repostType":2,"isVote":1,"tweetType":1,"viewCount":123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":250218315554944,"gmtCreate":1702107559939,"gmtModify":1702108891036,"author":{"id":"4133911624467882","authorId":"4133911624467882","name":"beherenow","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"If I could rewind time, I'd go to just before covid hit and invest into a large range of biotech firms, and also large online retailers, and then a bunch into AI related stocks.","listText":"If I could rewind time, I'd go to just before covid hit and invest into a large range of biotech firms, and also large online retailers, and then a bunch into AI related stocks.","text":"If I could rewind time, I'd go to just before covid hit and invest into a large range of biotech firms, and also large online retailers, and then a bunch into AI related stocks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/250218315554944","isVote":1,"tweetType":1,"viewCount":172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":248518477795488,"gmtCreate":1701711493457,"gmtModify":1701711530720,"author":{"id":"4133911624467882","authorId":"4133911624467882","name":"beherenow","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Keeping an eye on this.&nbsp;","listText":"Keeping an eye on this.&nbsp;","text":"Keeping an eye on this.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/248518477795488","repostId":"2388730643","repostType":2,"isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":247349132918872,"gmtCreate":1701425892401,"gmtModify":1701426923436,"author":{"id":"4133911624467882","authorId":"4133911624467882","name":"beherenow","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good tips.&nbsp;","listText":"Good tips.&nbsp;","text":"Good tips.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/247349132918872","repostId":"2387144222","repostType":4,"isVote":1,"tweetType":1,"viewCount":81,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":247349132918872,"gmtCreate":1701425892401,"gmtModify":1701426923436,"author":{"id":"4133911624467882","authorId":"4133911624467882","name":"beherenow","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good tips.&nbsp;","listText":"Good tips.&nbsp;","text":"Good tips.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/247349132918872","repostId":"2387144222","repostType":4,"repost":{"id":"2387144222","pubTimestamp":1701431435,"share":"https://www.laohu8.com/m/news/2387144222?lang=&edition=full","pubTime":"2023-12-01 19:50","market":"us","language":"en","title":"Ignore Nvidia: Here Are 3 Better Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2387144222","media":"Motley Fool","summary":"Nvidia may be changing the world, but its stock is too pricey.","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/NVDA\">Nvidia</a> is often seen as the poster child of the artificial intelligence (AI) investment movement, and for good reason: It&#39;s been a stellar performer in 2023. However, it has a lot of expectations built into the stock and is quite expensive compared to other promising investments.</p><p>So, instead of Nvidia, take a look at these other three stocks as potential portfolio-changing AI investments.</p><h2 id=\"id_3872153255\">1. <a href=\"https://laohu8.com/S/GOOGL\">Alphabet</a></h2><p>Alphabet is Google&#39;s parent company and has several investments within the AI space. However, it will see the most benefit in its Google Cloud division. Cloud computing is a great way for companies to develop AI models, as they can rent the computing resources rather than purchase them themselves. With Google Cloud specialized for many AI models (70% of generative AI companies valued over $1 billion use Google Cloud), it&#39;s a logical choice compared to others.</p><p>However, cloud computing is just a small part of the Alphabet investing thesis, comprising only 11% of revenue. The main part of investing in Alphabet is its advertising business, which is just starting to turn around now that the economic outlook is improving. It grew 9% in Q3, a significant acceleration from previous quarters.</p><p>This helped power Alphabet&#39;s earnings per share (EPS) figure to a new all-time high.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7ee59f6a849afe5c04fd7949ef85ec0c\" tg-width=\"720\" tg-height=\"451\"/></p><p>GOOGL EPS Basic (Quarterly) data by YCharts. EPS = earnings per share.</p><p>Alphabet is just hitting its stride, and with AI and its primary business starting to hit their stride as well, it makes for a much better investment than Nvidia right now.</p><h2 id=\"id_1869291214\">2. <a href=\"https://laohu8.com/S/ABNB\">Airbnb</a></h2><p>Airbnb doesn&#39;t seem like an AI stock, but its recent acquisition says otherwise. Airbnb acquired GamePlanner.AI, a company founded by the creators of Siri and Bixby. This adds to Airbnb&#39;s other AI tools it already uses on its platform, making it a backdoor AI investment.Before this acquisition, Airbnb was using AI to determine if a house was being rented out for parties, which is against its policies. Additionally, Airbnb&#39;s CEO and co-founder Brian Chesky stated earlier this year that &#34;The Holy Grail is becoming more like an AI travel agent that&#39;s the ultimate agent that can learn about you, and understand you.&#34;</p><p>If Airbnb can become the go-to AI travel agent, it will become a huge success.</p><p>But even though the stock isn&#39;t usually seen in this light, it makes for a fantastic buy right now. It grew revenue by 18% in Q3 and posted an impressive 44% free-cash-flow (FCF) margin. Airbnb is truly one of the top executing companies right now, but it can be had at a bargain-bin price.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9c08e1562d246f9856002b221b676567\" tg-width=\"720\" tg-height=\"451\"/></p><p>ABNB Price to Free Cash Flow data by YCharts.</p><p>At 20 times free cash flow, Airbnb stock is cheaply priced compared to many AI stocks. It also marks a diverse way to invest in AI with Airbnb&#39;s focus on travel.</p><h2 id=\"id_169667847\">3. <a href=\"https://laohu8.com/S/TSM\">Taiwan Semiconductor</a></h2><p>At the heart of nearly every high-power chip that powers graphics processing units (GPUs), smartphones, or other high-technology devices is a chip from Taiwan Semiconductor. Its best-in-class technology powers products made by Apple, Nvidia, and others, making Taiwan Semiconductor vital in the AI supply chain.</p><p>In 2023, Taiwan Semiconductor experienced a downturn in chip demand because of falling demand for consumer electronics. Because inventory for chips that power these devices is almost depleted, management has noted orders have started to pick up, which bodes well for 2024. Throw in increasing AI demand, and Taiwan Semiconductor looks primed for a great 2024.</p><p>Despite such a bright outlook, the stock trades at a historically low price-to-earnings (P/E) ratio.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/30019d9ab59431f64d96157e44f0d79d\" tg-width=\"720\" tg-height=\"451\"/></p><p>TSM PE Ratio data by YCharts. PE Ratio = price-to-earnings ratio.</p><p>Taiwan Semiconductor is a great way to invest in high technology without picking a specific winner. With its new 3-nanometer chip technology finally starting to contribute to revenue (6% of revenue in Q3), 2024&#39;s financials should be further bolstered.</p><p>While Nvidia as a company may be leading the AI revolution, I&#39;m less bullish on the stock due to its high valuation. I think Alphabet, Airbnb, and Taiwan Semiconductor each make for better ways to invest in AI right now, as all companies will still be successful regardless of how much AI changes the world.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ignore Nvidia: Here Are 3 Better Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIgnore Nvidia: Here Are 3 Better Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-12-01 19:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/11/30/ignore-nvidia-here-are-3-better-stocks/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nvidia is often seen as the poster child of the artificial intelligence (AI) investment movement, and for good reason: It's been a stellar performer in 2023. However, it has a lot of expectations ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/11/30/ignore-nvidia-here-are-3-better-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","ABNB":"爱彼迎","GOOGL":"谷歌A","GOOG":"谷歌"},"source_url":"https://www.fool.com/investing/2023/11/30/ignore-nvidia-here-are-3-better-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2387144222","content_text":"Nvidia is often seen as the poster child of the artificial intelligence (AI) investment movement, and for good reason: It's been a stellar performer in 2023. However, it has a lot of expectations built into the stock and is quite expensive compared to other promising investments.So, instead of Nvidia, take a look at these other three stocks as potential portfolio-changing AI investments.1. AlphabetAlphabet is Google's parent company and has several investments within the AI space. However, it will see the most benefit in its Google Cloud division. Cloud computing is a great way for companies to develop AI models, as they can rent the computing resources rather than purchase them themselves. With Google Cloud specialized for many AI models (70% of generative AI companies valued over $1 billion use Google Cloud), it's a logical choice compared to others.However, cloud computing is just a small part of the Alphabet investing thesis, comprising only 11% of revenue. The main part of investing in Alphabet is its advertising business, which is just starting to turn around now that the economic outlook is improving. It grew 9% in Q3, a significant acceleration from previous quarters.This helped power Alphabet's earnings per share (EPS) figure to a new all-time high.GOOGL EPS Basic (Quarterly) data by YCharts. EPS = earnings per share.Alphabet is just hitting its stride, and with AI and its primary business starting to hit their stride as well, it makes for a much better investment than Nvidia right now.2. AirbnbAirbnb doesn't seem like an AI stock, but its recent acquisition says otherwise. Airbnb acquired GamePlanner.AI, a company founded by the creators of Siri and Bixby. This adds to Airbnb's other AI tools it already uses on its platform, making it a backdoor AI investment.Before this acquisition, Airbnb was using AI to determine if a house was being rented out for parties, which is against its policies. Additionally, Airbnb's CEO and co-founder Brian Chesky stated earlier this year that \"The Holy Grail is becoming more like an AI travel agent that's the ultimate agent that can learn about you, and understand you.\"If Airbnb can become the go-to AI travel agent, it will become a huge success.But even though the stock isn't usually seen in this light, it makes for a fantastic buy right now. It grew revenue by 18% in Q3 and posted an impressive 44% free-cash-flow (FCF) margin. Airbnb is truly one of the top executing companies right now, but it can be had at a bargain-bin price.ABNB Price to Free Cash Flow data by YCharts.At 20 times free cash flow, Airbnb stock is cheaply priced compared to many AI stocks. It also marks a diverse way to invest in AI with Airbnb's focus on travel.3. Taiwan SemiconductorAt the heart of nearly every high-power chip that powers graphics processing units (GPUs), smartphones, or other high-technology devices is a chip from Taiwan Semiconductor. Its best-in-class technology powers products made by Apple, Nvidia, and others, making Taiwan Semiconductor vital in the AI supply chain.In 2023, Taiwan Semiconductor experienced a downturn in chip demand because of falling demand for consumer electronics. Because inventory for chips that power these devices is almost depleted, management has noted orders have started to pick up, which bodes well for 2024. Throw in increasing AI demand, and Taiwan Semiconductor looks primed for a great 2024.Despite such a bright outlook, the stock trades at a historically low price-to-earnings (P/E) ratio.TSM PE Ratio data by YCharts. PE Ratio = price-to-earnings ratio.Taiwan Semiconductor is a great way to invest in high technology without picking a specific winner. With its new 3-nanometer chip technology finally starting to contribute to revenue (6% of revenue in Q3), 2024's financials should be further bolstered.While Nvidia as a company may be leading the AI revolution, I'm less bullish on the stock due to its high valuation. I think Alphabet, Airbnb, and Taiwan Semiconductor each make for better ways to invest in AI right now, as all companies will still be successful regardless of how much AI changes the world.","news_type":1},"isVote":1,"tweetType":1,"viewCount":81,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":250218315554944,"gmtCreate":1702107559939,"gmtModify":1702108891036,"author":{"id":"4133911624467882","authorId":"4133911624467882","name":"beherenow","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"If I could rewind time, I'd go to just before covid hit and invest into a large range of biotech firms, and also large online retailers, and then a bunch into AI related stocks.","listText":"If I could rewind time, I'd go to just before covid hit and invest into a large range of biotech firms, and also large online retailers, and then a bunch into AI related stocks.","text":"If I could rewind time, I'd go to just before covid hit and invest into a large range of biotech firms, and also large online retailers, and then a bunch into AI related stocks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/250218315554944","isVote":1,"tweetType":1,"viewCount":172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":250584258953496,"gmtCreate":1702196866968,"gmtModify":1702197639190,"author":{"id":"4133911624467882","authorId":"4133911624467882","name":"beherenow","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Thanks for&nbsp; detailed and thorough article. Very helpful and plenty of useful information. Even if one doesn't follow the outlined strategy to a T, there's good info in stocks to buy, and other instruments.&nbsp;","listText":"Thanks for&nbsp; detailed and thorough article. Very helpful and plenty of useful information. Even if one doesn't follow the outlined strategy to a T, there's good info in stocks to buy, and other instruments.&nbsp;","text":"Thanks for detailed and thorough article. Very helpful and plenty of useful information. Even if one doesn't follow the outlined strategy to a T, there's good info in stocks to buy, and other instruments.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/250584258953496","repostId":"2390181028","repostType":2,"isVote":1,"tweetType":1,"viewCount":123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":248518477795488,"gmtCreate":1701711493457,"gmtModify":1701711530720,"author":{"id":"4133911624467882","authorId":"4133911624467882","name":"beherenow","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Keeping an eye on this.&nbsp;","listText":"Keeping an eye on this.&nbsp;","text":"Keeping an eye on this.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/248518477795488","repostId":"2388730643","repostType":2,"repost":{"id":"2388730643","pubTimestamp":1701700558,"share":"https://www.laohu8.com/m/news/2388730643?lang=&edition=full","pubTime":"2023-12-04 22:35","market":"us","language":"en","title":"RedHill secures funding for Phase 2 study of COVID-19 treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2388730643","media":"seekingalpha","summary":"RedHill  said it has received new non-dilutive external funding for a Phase 2 study of its oral antiviral drug RHB-107 in the treatment of early COVID-19. The Israeli company said the approximately $4.8M in funding will cover the entirety of the RHB-107 arm of the ACESO PROTECT study for early COVID-19 outpatient treatment. The study, which will have 300 patients, is expected to begin enrollment in the coming weeks and be completed by the end of 2024. If approved, the product could provide an additional option to Pfizer’s  Paxlovid in the early COVID-19 treatment space, RedHill said.   More on RedHill  RedHill stock nearly doubles in value pre-market on a five-year FDA exclusivity grant Financial information for RedHill","content":"<html><body><p>RedHill (<span>NASDAQ:RDHL</span>) said it has received new non-dilutive external funding for a Phase 2 study of its oral antiviral drug RHB-107 in the treatment of early COVID-19.</p> <p>The Israeli company said the approximately $4.8M in funding will cover the entirety of<span> the RHB-107 arm of the ACESO PROTECT study for early COVID-19 outpatient treatment.</span></p> <p>The study, which will have 300 patients, is expected to begin enrollment in the coming weeks and be completed by the end of 2024.</p> <p>If approved, the product could provide an additional option to Pfizer’s (PFE) Paxlovid in the early COVID-19 treatment space, RedHill said. </p> <div> <h2>More on RedHill</h2> <ul> <li>RedHill stock nearly doubles in value pre-market on a five-year FDA exclusivity grant</li> <li>Financial information for RedHill</li> </ul> </div></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RedHill secures funding for Phase 2 study of COVID-19 treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRedHill secures funding for Phase 2 study of COVID-19 treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-12-04 22:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4042841-redhill-secures-funding-for-phase-2-study-of-covid-19-treatment><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>RedHill (NASDAQ:RDHL) said it has received new non-dilutive external funding for a Phase 2 study of its oral antiviral drug RHB-107 in the treatment of early COVID-19. The Israeli company said the ...</p>\n\n<a href=\"https://seekingalpha.com/news/4042841-redhill-secures-funding-for-phase-2-study-of-covid-19-treatment\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1332149063/image_1332149063.jpg","relate_stocks":{"LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","BK4551":"寇图资本持仓","RDHL":"Redhill Biopharma Ltd","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BNTX":"BioNTech SE","BK4568":"美国抗疫概念","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4581":"高盛持仓","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU0234572021.USD":"高盛美国核心股票组合Acc","SG9999002232.USD":"Allianz Global High Payout USD","BK4548":"巴美列捷福持仓","LU0058720904.USD":"联博国际健康护理基金A","SG9999002224.SGD":"Allianz Global High Payout SGD","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","BK4588":"碎股","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","BK4592":"伊斯兰概念","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU0122379950.USD":"贝莱德世界健康科学A2","BK4585":"ETF&股票定投概念","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","BK4534":"瑞士信贷持仓","BK4139":"生物科技","PFE":"辉瑞","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","SG9999001176.USD":"United Global Healthcare Acc USD","BK4535":"淡马锡持仓","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","BK4550":"红杉资本持仓","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H"},"source_url":"https://seekingalpha.com/news/4042841-redhill-secures-funding-for-phase-2-study-of-covid-19-treatment","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2388730643","content_text":"RedHill (NASDAQ:RDHL) said it has received new non-dilutive external funding for a Phase 2 study of its oral antiviral drug RHB-107 in the treatment of early COVID-19. The Israeli company said the approximately $4.8M in funding will cover the entirety of the RHB-107 arm of the ACESO PROTECT study for early COVID-19 outpatient treatment. The study, which will have 300 patients, is expected to begin enrollment in the coming weeks and be completed by the end of 2024. If approved, the product could provide an additional option to Pfizer’s (PFE) Paxlovid in the early COVID-19 treatment space, RedHill said.   More on RedHill  RedHill stock nearly doubles in value pre-market on a five-year FDA exclusivity grant Financial information for RedHill","news_type":1},"isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}